All stock lists
Nuveen Municipal Value Fund Inc (New York Stock Exchange:NUV)
US · Delayed Price · Currency is USD
Financial Services · Asset Management
8.36+0.08 (+0.97%)
Market cap
$1.74B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 17, 1987
Website
Insider Score
––Not scored
NUV Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Financial Health Score
Strong
From NUV’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $138.9M
- Net income
- $144.6M
- Net margin
- 104.2%
Leverage17 / 20
Little or no net debt.
- Total debt
- $120.8M
- Cash
- $6.4M
- Net debt / EBITDA
- 0.69x
Liquidity—
Current assets or liabilities not reported.
- Current assets
- $34.5M
- Current liabilities
- $0
- Current ratio
- —
Cash generation11 / 20
Roughly cash-neutral.
- Operating cash flow
- $0
- Free cash flow
- $0
- FCF margin
- 0.0%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 208.6M
- Share growth (1y)
- 0.5%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
NUV Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Apr 30, 2026 | Oct 31, 2025 | Apr 30, 2025 | Oct 31, 2024 | Apr 30, 2024 | Oct 31, 2023 |
| Revenue | 41.11 M | 44.75 M | 22.06 M | 30.96 M | 41.91 M | 38.75 M |
| Revenue Growth (YoY) | -1.90 % | 15.47 % | -46.10 % | 263.18 % | 53.56 % | -14.57 % |
| Cost of Revenue | 4.76 M | 4.67 M | 4.71 M | -8.20 M | 4.71 M | 4.55 M |
| Gross Profit | 36.35 M | 35.36 M | 22.06 M | 21.81 M | 20.96 M | 20.66 M |
| SG&A Expense | 0.00 | -1.74 M | 2.40 M | 4.93 M | 4.81 M | 4.69 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 11.24 M | -54.86 M | 2.40 M | 2.47 M | 2.41 M | -111.91 M |
| Operating Income | 25.11 M | 42.83 M | 19.66 M | 162.95 M | 37.10 M | 36.63 M |
| Pretax Income | 23.30 M | 69.84 M | -10.08 M | 51.51 M | 147.33 M | -98.36 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 358.28 K | 0.00 | 0.00 |
| Net Income | 23.30 M | 79.91 M | -10.08 M | 51.51 M | 147.33 M | -98.36 M |
| EPS (Basic) | 0.11 | 0.39 | -0.05 | 0.25 | 0.71 | -0.47 |
| EPS (Diluted) | 0.11 | 0.39 | -0.05 | 0.25 | 0.71 | -0.47 |
| Shares Outstanding | 208.57 M | 207.54 M | 207.54 M | 207.54 M | 207.54 M | 207.54 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.